Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1089/dia.2020.0206 http://scihub22266oqcxt.onion/10.1089/dia.2020.0206 32396395!7262638!32396395     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Diabetes+Technol+Ther 2020 ; 22 (6): 444-448 Nephropedia Template TP {{tp|p=32396395|t=2020. Inpatient Transition to Virtual Care During COVID-19 Pandemic |pdf=|usr=}}{{32396395}} gab.com Text Inpatient Transition to Virtual Care During COVID-19 Pandemic JO: Diabetes Technol Ther http://www.kidney.de/pget.php?&tw=1&pmid=32396395 #FOAvip Introduction: During the coronavirus disease 2019 (COVID-19) outbreak, novel approaches to diabetes care have been employed. Care in both the inpatient and outpatient setting has transformed considerably. Driven by the need to reduce the use of personal protective equipment and exposure for patients and providers alike, we transitioned inpatient diabetes management services to largely "virtual" or remotely provided care at our hospital. Methods: Implementation of a diabetes co-management service under the direction of the University of North Carolina division of endocrinology was initiated in July 2019. In response to the COVID-19 pandemic, the diabetes service was largely transitioned to a virtual care model in March 2020. Automatic consults for COVID-19 patients were implemented. Glycemic outcomes from before and after transition to virtual care were evaluated. Results: Data over a 15-week period suggest that using virtual care for diabetes management in the hospital is feasible and can provide similar outcomes to traditional face-to-face care. Conclusion: Automatic consults for COVID-19 patients ensure that patients with serious illness receive specialized diabetes care. Transitioning to virtual care models does not limit the glycemic outcomes of inpatient diabetes care and should be employed to reduce patient and provider exposure in the setting of COVID-19. These findings may have implications for reducing nosocomial infection in less challenging times and might address shortage of health care providers, especially in the remote areas. Twit Text FOAVip Inpatient Transition to Virtual Care During COVID-19 Pandemic ????Diabetes Technol Ther http://www.kidney.de/pget.php?&tw=1&pmid=32396395 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32396395 #FOAvip English Wikipedia <ref>{{Cite pmid|32396395}}</ref> Inpatient Transition to Virtual Care During COVID-19 Pandemic #MMPMID32396395 Jones MS; Goley AL; Alexander BE; Keller SB; Caldwell MM; Buse JB Diabetes Technol Ther 2020[Jun]; 22 (6): 444-448 PMID32396395show ga Introduction: During the coronavirus disease 2019 (COVID-19) outbreak, novel approaches to diabetes care have been employed. Care in both the inpatient and outpatient setting has transformed considerably. Driven by the need to reduce the use of personal protective equipment and exposure for patients and providers alike, we transitioned inpatient diabetes management services to largely "virtual" or remotely provided care at our hospital. Methods: Implementation of a diabetes co-management service under the direction of the University of North Carolina division of endocrinology was initiated in July 2019. In response to the COVID-19 pandemic, the diabetes service was largely transitioned to a virtual care model in March 2020. Automatic consults for COVID-19 patients were implemented. Glycemic outcomes from before and after transition to virtual care were evaluated. Results: Data over a 15-week period suggest that using virtual care for diabetes management in the hospital is feasible and can provide similar outcomes to traditional face-to-face care. Conclusion: Automatic consults for COVID-19 patients ensure that patients with serious illness receive specialized diabetes care. Transitioning to virtual care models does not limit the glycemic outcomes of inpatient diabetes care and should be employed to reduce patient and provider exposure in the setting of COVID-19. These findings may have implications for reducing nosocomial infection in less challenging times and might address shortage of health care providers, especially in the remote areas. |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/complications/*prevention & control[MESH] |Cross Infection/*prevention & control/virology[MESH] |Diabetes Mellitus/*therapy/virology[MESH] |Feasibility Studies[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Pandemics/*prevention & control[MESH] |Patient Care Team[MESH] |Patient Transfer/*methods[MESH] |Pneumonia, Viral/complications/*prevention & control[MESH] |SARS-CoV-2[MESH]Inpatient Transition to Virtual Care During COVID-19 Pandemic (epmc).pdf DeepDyve Pubget Overpricing